EnerDynamic Hybrid Technologies - Announces Co-Operation Agreement with Scattered Gold Biotechnology Inc.
NIAGRA FALLS and LONDON, ONTARIO / ACCESSWIRE / October 21, 2019 / EnerDynamic Hybrid Technologies Corp. (TSXV:EHT) ("EHT") is pleased to announce a co-operation agreement with Scattered Gold Biotechnology Inc. ("SGB").
SGB and EHT have signed the co-operation agreement for the purpose of developing customized cultivation units to form the basis of a Good Manufacturing Practice (GMP)-compliant facility in North Bay, Ontario. With the assistance of Canadore College, the facility will focus on the process of producing recombinant proteins from genetically-engineered "green plant bioreactors", and will utilize Growratio's advanced Controlled Environment Agriculture (CEA) platform to orchestrate and replicate the precise environmental protocols required for pharmaceutical grade biomass production at scale.
SGB has developed several plant bioreactor lines (genetically-engineered tobacco) that express and accumulate various recombinant proteins at very high levels, making the process of "upstream production" (biomass generation before extraction/purification) compellingly cost-effective and eco-friendly.
SGB is interested in the generation of a GMP-compliant facility and the process of production for select recombinant proteins, including potential biopharmaceuticals for human use. SGB and EHT's mutual interest is in the integration of EHT's cultivation units as an "upstream production module", which will utilize Growratio's patented lighting and proprietary control systems to deliver advanced environmental ‘recipes', including customized spectral tuning algorithms to drive efficiencies in photosynthesis and photomorphogenesis for the consistent generation of plant bioreactor biomass for downstream processing and purification of the recombinant protein product.
SGB and EHT believe once a production model of a GMP-compliant facility is completed, the process design will generate valuable IP, opening opportunities for other companies to licence the technology from SGB and EHT. As market for recombinant proteins grows rapidly worldwide, advancements in large-scale production technologies are imperative to supply the growing demand. Current conventional processes for manufacturing of recombinant proteins use bioreactors (fermenters) to cultivate bacterial, insect or mammalian cells. Bioreactors are generally costly to build, and energy-inefficient in operation due to the use of highly-processed input materials. They also have limited scalability, often rendering the product prohibitively expensive. The use of the combined technology (SGB,EHT and Growratio) is aimed at fully-controlled cultivation of "green plant bioreactors" and is expected to bring the price point down significantly, benefiting consumers.
EHT's CEO, John Gamble, commented, "This is a major advancement for our company; we have confirmed our market entry into the biopharma sector with SGB selecting our micro grow technology to provide the necessary plant growth for the production of recombinant proteins. We look forward to our entry into the biopharmaceutical sector and expanding our technology presence both in Canada and globally with our partner Growratio."
https://web.tmxmoney.com/article.php?newsid=6659390604249530&qm_symbol=EHT